US2019307780A1PendingUtilityA1
Anti-Inflammatory Compounds and Uses Thereof
Assignee: MEDICON PHARMACEUTICALS INCPriority: Aug 10, 2007Filed: Jul 13, 2018Published: Oct 10, 2019
Est. expiryAug 10, 2027(~1 yrs left)· nominal 20-yr term from priority
Inventors:Basil Rigas
A61P 37/02A61P 37/00A61P 37/06A61P 35/02A61P 9/14A61P 9/10A61P 9/12A61P 9/00A61P 43/00A61P 35/00A61P 25/00A61P 25/28A61P 29/00A61P 27/02A61P 13/08A61P 11/02A61P 11/00A61P 19/04A61P 19/02A61P 1/04A61P 11/08C07F 9/094C07F 9/093C07F 9/65742A61K 31/6615A61K 31/661C07F 9/091
63
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Compounds of the general formula are disclosed with activity towards treating diseases related to inflammation, such as cancer, neurodegenerative and cardiovascular diseases. Pharmaceutical compositions and methods of use are also described.
Claims
exact text as granted — not AI-modified1 . (canceled)
2 . A method of treating a disease or disorder in a subject in need thereof, the method comprising administering to the subject a composition comprising a pharmaceutically acceptable excipient and a compound of Formula (I):
or a salt thereof, wherein in Formula (I):
A is selected from the group consisting of:
B is selected from the group consisting of:
D is
and
n is 1 or 2.
3 . The method of claim 2 , wherein the disease or disorder is selected from an inflammation related disease or disorder, a neurodegenerative disease or disorder, an autoimmune disease or disorder, and a proliferative disease or disorder.
4 . The method of claim 2 , wherein the inflammation related disease or disorder is selected from a rheumatologic disease, a cardiovascular disease, a neurodegenerative disease, a cerebrovascular disease, an autoimmune disease, a chronic inflammation disease, a neoplastic disease, and a pre-neoplastic disease.
5 . The method of claim 3 , wherein the proliferative disease or disorder is cancer.
6 . The method of claim 5 , wherein the cancer is selected from prostate cancer, colon adenomas, colon cancer, lung cancer, breast cancer, pancreatic cancer, of the lung, lymphoma and leukemia.
7 . The method of claim 2 , wherein the compound of Formula (I) is:
8 . The method of claim 2 , wherein the compound of Formula (I) is:
9 . The method of claim 2 , wherein the compound of Formula (I) is:
10 . The method of claim 2 , wherein the compound of Formula (I) is:
11 . The method of claim 2 , wherein the compound of Formula (I) is:
12 . The method of claim 2 , wherein the compound of Formula (I) is:
13 . The method of claim 2 , wherein the compound of Formula (I) is:
14 . The method of claim 2 , wherein the compound of Formula (I) is:
15 . The method of claim 2 , wherein the compound of Formula (I) is:
16 . The method of claim 2 , wherein the compound of Formula (I) is:
17 . The method of claim 2 , wherein the compound of Formula (I) is:
18 . The method of claim 2 , wherein the compound of Formula (I) is:
19 . The method of claim 2 , wherein the compound of Formula (I) is:
20 . The method of claim 2 , wherein the compound of Formula (I) is:
21 . The method of claim 2 , wherein the compound of Formula (I) is:Join the waitlist — get patent alerts
Track US2019307780A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.